Modulation of cyclooxygenase in endothelial cells by fibronectin: Relevance to angiogenesis

Journal of Cellular Biochemistry

Volumn 105, Issue 1, 2008, Pages 158-166

  Viji, R I ^a   Sameer Kumar, V B ^a   Kiran, M S ^a   Sudhakaran, P R ^a  

^a UNIVERSITY OF KERALA   (India)

Author keywords

COX 2; Fibronectin; HUVECs; Prostaglandins; VEGF

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CD31 ANTIGEN; COLLAGEN TYPE 1; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRONECTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; POLYLYSINE; PROSTAGLANDIN D2; PROSTAGLANDIN E2; VASCULOTROPIN; VERY LATE ACTIVATION ANTIGEN 5; WORTMANNIN;

ANGIOGENESIS; ARTICLE; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN;

BIOLOGICAL MARKERS; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FIBRONECTINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROSTAGLANDIN D2; PROTEIN KINASE INHIBITORS; RNA, MESSENGER;

EID: 51849115894     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21808     Document Type: Article

References (52)

1. Ben-Av P, Crofford LJ, Wilder RL, Hla T. 1995. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis. FEBS Lett 372:83-87.
2. 2. J Biol Chem 274:17042-17048.
3. Cho MK, Cho YH, Lee GH, Kim SG. 2004. Induction of cyclooxygenase-2 by bovine type I collagen in macrophages via C/EBP and CREB activation by multiple cell signaling pathways. Biochem Pharmacol 67:2239-2250.
4. Cianchi F, Cortesini C, Bechi P, Fantappie O, Messerini L, Vannacci A, Sardi I, Baroni G, Boddi V, Mazzanti R, Masini E. 2001. Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterol 121:1339-1347.
5. Daniel TO, Liu H, Morrow JD, Crews BC, Marnett LJ. 1999. Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res 59:4574-4577.
6. Diaz A, Chepenik KP, Korn JH, Reginato AM, Jimenez SA. 1998. Differential regulation of cyclooxygenases 1 and 2 by interleukin-1β, tumor necrosis factor-α, and transforming growth factor-β1 in human lung fibroblasts. Exp Cell Res 241:222-229.
7. Dixon DA. 2004. Dysregulated post-transcriptional control of COX-2 gene expression in cancer. Curr Pharm Des 10:635-646.
8. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LBA, Lipsky PE. 1998. Cyclooxygenase in biology and disease. FASEB J 12:1063-1073.
9. Engvall E, Perlman P. 1971. Enzyme-linked immunosorbent assay (ELISA): Quantitative assay of immunoglobulin. Immunochemistry 8:871-874.
10. 2 and angiogenesis. Proc Soc Exp Biol Med 172:214-218.
11. Fritsche E, Baek SJ, King LM, Zeldin DC, Eling TE, Bell DA. 2001. Functional characterization of cyclooxygenase-2 polymorphisms. J Pharmacol Exp Ther 299:468-476.
12. Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V, Chiarugi V, Masini E. 2001. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia 3:53-61.
13. Graeber JE, Glaser BM, Setty BNY, Jerdan JA, Walenga RW, Stuart MJ. 1990. 15-Hydroxyeicosatetraenoic acid stimulates migration of human retinal microvessel endothelium in vitro and neovascularization in vivo. Prostaglandins 39:665-673.
14. Han S, Sidell N, Roser-Page S, Roman J. 2004. Fibronectin stimulates human lung carcinoma cell growth by inducing cyclooxygenase-2 (COX-2) expression. Int J Cancer 111:322-331.
15. Holtmann H, Shemer-Avni Y, Wessel K, Sarov I, Wallach D. 1990. Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesis. Infect Immun 58:3168-3172.
16. Huang S, Pettaway CA, Uehara H, Bucana CD, Fidler IJ. 2001. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 20: 4188-4197.
17. Hull MA, Thomson JL, Hawkey CJ. 1999. Expression of cyclooxygenase 1 and 2 by human gastric endothelial cells. Gut 45:529-536.
18. Hynes RO. 1999. Cell adhesion: Old and new questions. Trends Cell Biol 9:M33-M37.
19. Jaffe EA, Nachman RL, Becker CG, Minick CR. 1973. Culture of human endothelial cells from umbilical veins: Identification by morphologic and immunologic criteria. J Clin Invest 52:2745-2746.
20. Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS. 1999. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 5:1418-1423.
21. Khan KMF, Howe LR, Falcone DJ. 2004. Extracellular matrix-induced cyclooxygenase-2 regulates macrophage proteinase expression. J Biol Chem 279:22039-22046.
22. Kiran MS, Sameer Kumar VB, Viji RI, Sudhakaran PR. 2006. Temporal relationship between MMP production and angiogenic process in HUVECs. Cell Biol Int 30:704-713.
23. Kumar VBS, Viji RI, Kiran MS, Sudhakaran PR. 2007. Endothelial cell response to lactate: Implication of PAR modification of VEGF. J Cell Physiol 211:477-485.
24. Lo'pez S, Vila L, Breviario F, de Castellarnau C. 1993. Interleukin-1 increases 15-hydroxyeicosatetraenoic acid formation in cultured human endothelial cells. Biochim Biophys Acta 1170:17-24.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
26. Marnett LJ, Kalgutkar AS. 1999. Cyclooxygenase 2 inhibitors: Discovery, selectivity and the future. Trends Pharmacol Sci 20:465-469.
27. 3. Br J Haematol 121:157-164.
28. Nakagawa T, Fujita N, Oh-Hara T, Kurokawa T, Nakamura K, Tsuruo T. 1999. Interleukin-1alpha induces cyclooxygenase-2 expression in bone-derived endothelial cells. J Cell Physiol 179:226-232.
29. Namkoong S, Lee SJ, Kim CK, Kim YM, Chung HT, Lee H, Han JA, Ha KS, Kwon YG, Kim YM. 2005. Prostaglandin E2 stimulates angiogenesis by activating the nitric oxide/cGMP pathway in human umbilical vein endothelial cells. Exp Mol Med 37:588-600.
30. Pai R, Szabo IL, Soreghan BA, Atay S, Kawanaka H, Tarnawski AS. 2001. PGE(2) stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways. Biochem Biophys Res Commun 286:923-928.
31. Ramsay RG, Ciznadija D, Vanevski M, Mantamadiotis T. 2003. Transcriptional regulation of cyclo-oxygenase expression: Three pillars of control. Int J Immunopathol Pharmacol 16:59-67.
32. Risau W, Lemmon V. 1988. Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev Biol 125:441-450.
33. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, Santoro MG. 2000. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of I kappa B kinase. Nature 403:103-108.
34. Ruegg C, Mariotti A. 2003. Vascular integrins: Pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis. Cell Mol Life Sci 60:1135-1157.
35. Ruegg C, Zaric J, Stupp R. 2003. Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: Hypes, hopes and reality. Ann Med 35:476-487.
36. Schmedtje JF Jr, Ji YS, Liu W-L, DuBois RN, Runge MS. 1997. Hypoxia induces cyclooxygenase-2 via the NF-kappa B p65 transcription factor in human vascular endothelial cells. J Biol Chem 272:601-608.
37. Seno H, Oshima M, Ishikawa TO, Oshima H, Takaku K, Chiba T, Narumiya S, Taketo MM. 2002. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps. Cancer Res 62:506-511.
38. Tamura M, Sebastian S, Gurates B, Yang S, Fang Z, Bulun SE. 2002. Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells. J Clin Endocrinol Metab 87:3504-3507.
39. Tanabe T, Tohnai N. 2002. Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat 68-69:95-114.
40. Tazawa R, Xu XM, Wu KK, Wang LH. 1994. Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene. Biochem Biophys Res Commun 203:190-199.
41. Tsuji S, Kawano S, Tsujii M, Michida T, Masuda E, Gunawan ES, Hori M. 1998. Mucosal microcirculation and angiogenesis in gastrointestinal tract. Nippon Rinsho 56:2247-2252.
42. Tsujii M, DuBois RN. 1995. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83:493-501.
43. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. 1998. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705-716.
44. Uracz W, Uracz D, Olszanecki R, Gryglewski RJ. 2002. Interleukin 1beta induces functional prostaglandin E synthase in cultured human umbilical vein endothelial cells. J Physiol Pharmacol 53:643-654.
45. Viji RI, Kumar VBS, Kiran MS, Sudhakaran PR. 2008. Angiogenic response of endothelial cells to heparin binding domain of fibronectin. Int J Biochem Cell Biol 40:215-226.
46. Williams CS, DuBois RN. 1996. Prostaglandin endoperoxide synthase: Why two isoforms? Am J Physiol Gastrointest Liver Physiol 270:G393-G400.
47. Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. 2000. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 105:1589-1594.
48. Xin X, Yang S, Kowalski J, Gerritsen ME. 1999. Peroxisome proliferator-activated receptor γ ligands are potent inhibitors of angiogenesis in vitro and in vivo. J Biol Chem 274:9116-9121.
49. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. 2000. Vascular-specific growth factors and blood vessel formation. Nature 407:242-248.
50. Yazawa K, Nelson H, Tsuno NH, Kitayama J, Kawai K, Okaji Y, Asakage M, Sunami E, Kaisaki S, Hori N, Watanabe T, Takahashi K, Nagawa H. 2005. Selective inhibition of cyclooxygenase (COX)-2 inhibits endothelial cell proliferation by induction of cell cycle arrest. Int J Cancer 113:541-548.
51. Zaric J, Ruegg C. 2005. Integrin-mediated adhesion and soluble ligand binding stabilize COX-2 protein levels in endothelial cells by inducing expression and preventing degradation. J Biol Chem 280:1077-1085.
52. Ziche M, Jones J, Guilino PM. 1982. Role of prostaglandin E1 and copper in angiogenesis. J Natl Cancer Inst 69:475-482.